Copyright
©The Author(s) 2019.
World J Gastroenterol. Mar 21, 2019; 25(11): 1307-1326
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1307
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1307
Test | Description | Accuracy | Advantages | Disadvantages | Guideline recommendation |
VCTE | Measuring the velocity of a 50 mHz shear wave, which is positively related to liver stiffness | AUROC 0.83, 0.87, and 0.92 , respectively, for AF, SF, and cirrhosis with M probe[28]; AUROC 0.82, 0.86, and 0.94, respectively, for AF, SF, and cirrhosis with XL probe[117] | Relatively low cost; Good reproducibility Short processing time; Can be used in ambulatory clinic setting | Fasting for 2 h; Device- and operator- dependency; Influenced by obesity, congestion, and inflammation; Uncertain cut-off values; Intermediate stages due to two cut-offs | FibroScan can be used to identify those at low or high risk for AF[32,34] |
SWE | A method integrated into conventional ultrasound provides a 2-D, real-time, color map of liver elasticity | AUROC 0.86, 0.89, and 0.88, respectively, for AF, SF, and cirrhosis[123] | Good reproducibility; Not affected by obesity or ascites | Relatively high cost; Fasting for 2 h; Device- and operator- dependency; Quality criteria not well defined | NA |
ARFI | A method integrated into a conventional ultrasound measures shear wave speed | AUROC 0.77, 0.84, and 0.84, respectively, for AF, SF, and cirrhosis[123] | Good reproducibility; Not affected by obesity or ascites ROI smaller than transient elastography | High cost; Fasting for 2 h; Device- and operator- dependency; Quality criteria not well defined; Intermediate stages due to two cut-offs | NA |
MRE | A noninvasive MRI based method measures liver stiffness by a modified phase-contrast method | AUROC 0.87, 0.90, and 0.91, respectively, for AF, SF, and cirrhosis[131] | Good reproducibility; Not affected by obesity or ascites | High cost; Time consuming; Fasting for 2 h; Device- and operator- dependency; Intermediate stages due to two cut-offs | MRE is clinically useful tools for identifying advanced fibrosis in patients with nonalcoholic fatty liver disease[34] |
- Citation: Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J Gastroenterol 2019; 25(11): 1307-1326
- URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1307.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i11.1307